Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × zimberelimab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Kidney Neoplasms 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Melanoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Bile Duct Neoplasms 1

Interventions

pembrolizumab 10 avelumab 8 Nivolumab 7 Specimen Handling 4 Ipilimumab 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiosurgery 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡